Rejected
at 10:01 p.m. Jan, 23, 2024 ]
by
herstein.jacob
Author:
lynnit
Type of change:
Updated content
Rationale for change
Uworld provided 3 range of viral load for specific management
Source: UWorld - Step 2 3678
Rejection reason
QID says "patients with viral load ≤1,000 copies/mL may deliver vaginally without intrapartum zidovudine (AZT)" and AMBOSS supports the fact that 50-1000 is individualized decision regarding AZT
Current
Suggested
Text
Text
One by one
One by one
Text
Text
One by one
One by one
Extra
Pregnancy | Viral load (copies/mL) | Route of delivery | Antiretroviral therapy (ART) |
---|---|---|---|
≤ 50 | Vaginal delivery | IV zidovudine not recommended | |
> 50 - ≤ 1000 | |||
> 1000 OR unknown viral load OR poor adherence to ARV treatment | C-section at 38 weeks | IV zidovudine 3 hours prior to delivery | |
Newborn | Viral load (copies/mL) | Antiretroviral therapy (ART) | |
≤ 50 | Zidovudine within 12 hours after birth for 4 weeks | ||
> 50 | Combo ART therapy: 3-drug combo regimen for 6 weeks |
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
Empty field
OME
Additional Resources